ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Income Statement

314 Followers

ARS Pharmaceuticals Income Statement

Last quarter (Q2 2024), ARS Pharmaceuticals's total revenue was $500.00K, an increase of 4900.00% from the same quarter last year. In Q2, ARS Pharmaceuticals's net income was $-12.52M. See ARS Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 500.00K$ 30.00K$ 1.32M$ 5.51M$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
$ 500.00K$ 30.00K$ 1.32M$ 5.51M--
Operating Expense
$ 57.24M$ 67.55M$ 36.83M$ 24.96M$ 32.92M$ 24.07M
Operating Income
$ -56.74M$ -67.52M$ -35.52M$ -19.45M$ -32.92M$ -24.07M
Net Non Operating Interest Income Expense
---$ 106.00K$ -29.00K$ 100.00K
Other Income Expense
$ -11.89M$ 13.15M$ -834.00K$ 789.00K--
Pretax Income
$ -44.84M$ -54.37M$ -34.68M$ -20.24M$ -32.95M$ -23.97M
Tax Provision
$ -88.00K$ -88.00K$ -21.00K$ -38.00K--
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -44.84M$ -54.37M$ -34.68M$ -20.24M$ -32.95M$ -23.97M
Basic EPS
$ -0.47$ -0.57$ -0.87$ -0.70$ -11.33$ -4.90
Diluted EPS
$ -0.47$ -0.57$ -0.87$ -0.70$ -11.33$ -4.90
Basic Average Shares
$ 385.04M$ 95.22M$ 39.96M$ 28.87M$ 2.91M$ 4.89M
Diluted Average Shares
$ 385.04M$ 95.22M$ 39.96M$ 28.87M$ 2.91M$ 4.89M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 57.24M$ 67.55M$ 36.83M$ 24.96M$ 32.92M$ 24.07M
Net Income From Continuing And Discontinued Operation
$ -44.84M$ -54.37M$ -34.68M$ -20.24M$ -32.95M$ -23.97M
Normalized Income
$ -31.39M$ -54.45M--$ -32.95M$ -23.97M
Interest Expense
------
EBIT
$ -53.62M$ -67.52M$ -34.68M$ -20.24M$ -32.92M$ -24.07M
EBITDA
$ -38.76M$ -67.52M$ -34.68M$ -20.24M$ -32.28M$ -23.52M
Currency in USD

ARS Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis